Low Dose Dexmedetomidine as a Postoperative Pain Adjunct

Enrolling by invitation · Phase 4

Conditions studied: Spinal Fusion, Adolescent Idiopathic Scoliosis

In brief

This randomized controlled trial examines whether the addition of a low-dose dexmedetomidine infusion to our current multimodal pain management plan decreases narcotic consumption and reduces side effects in adolescent patients undergoing posterior spinal fusion for idiopathic scoliosis.

Key facts

Study ID

NCT06067893

Run by

Nichole Doyle

People needed

160

Starts

2024-07-01

Expected to finish

2027-07-01

Last updated by the study team

2026-08-03

Who can join

Age: 10 and older, up to 21. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Diagnosis of idiopathic scoliosis
• Undergoing a posterior spinal fusion of at least 5 levels with both thoracic and lumbar involvement

You may not qualify if…

• Known allergy to dexmedetomidine or any of the standard medications used intra or post operatively
• Patients with a history of chronic pain currently taking opioids, TCA's, Gabapentinoids
• Medical contraindications to administration of dexmedetomidine, unstable cardiac status, (prolonged Qtc, life threatening arrhythmias, use of digoxin)
• Moya Moya disease

Where it is running

• Children's Mercy Hospital — Kansas City, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.